Search

everythinglearnresearchcommunity

for

Search:↓

The combined Selencin treatment effectively reduces hair loss and improves hair health after COVID-19.

Scalp biopsy and digital phototrichogram help diagnose and manage different types of diffuse hair loss.

The man's hair loss was due to syphilis, and his hair regrew after treatment.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Unani medicine effectively reduced hair loss in a 24-year-old woman without side effects.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Hidden sweat gland tumors might cause hair loss.

Many women's hair loss is due to health issues, medication, nutrition, or stress.

Unani medicine links diffuse hair loss to poor skin pore function and body dryness, leading to thinning hair.

High levels of prolactin in the blood can be linked to widespread hair loss.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

Sertraline can cause hair loss, which stops after stopping the drug.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

There is no clear link between low serum ferritin and chronic diffuse telogen hair loss.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

A 62-year-old woman with hair loss and scalp itching was diagnosed with lichen planopilaris, treated initially with topical corticosteroids, and other possible treatments include systemic steroids, antimalarials, and more.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The document explains how to claim CME credit by diagnosing and treating hair loss conditions in two patient cases.

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

Female pattern hair loss is common and increases with age.

Amphetamine use may not cause hair loss, "geezer" traits are normal aging, not all educated older people are stereotypes, and metronidazole can rarely cause lung disease.

Amphetamines may not directly cause hair loss.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.